PRWeb The Leader Press Release Distribution
See How PRWeb Works

We're here to help 1-866-640-6397

Login Create Free Account


All Press Releases for November 6, 2009 Add to my Yahoo! Subscribe to this News Feed Subscribe to this News Feed   
 

Randy Olver Named Emdat CEO, Will Lead Next Phase of Growth for Medical Transcription Solutions Provider

Emdat, a world leader in online-based medical transcription, has tapped Randy Olver as its new CEO, effective immediately.

It’s a critical time for medical software and I am very confident in the ability of Emdat’s people and technology to evolve with industry changes and to set the pace for improvements

(Vocus/PRWEB ) November 6, 2009 -- Emdat, a world leader in online-based medical transcription, has tapped Randy Olver as its new CEO, effective immediately.

Randy Olver
Randy Olver

Emdat’s founding partners, who remain actively involved in the business, selected Olver to serve as CEO of the 10-year-old company. Steve Palmisano, one of the founders who had been CEO, will serve as president.

“Randy’s diverse business experience is exactly what we’ve been seeking to guide Emdat to the next level so that we can continue providing world-class transcription products and services to our clients,” Palmisano said. “We’ve tripled in size in the past five years and, looking forward, our business needs have grown dramatically.”

Emdat, which experienced double-digit growth during the difficult business environment of the past year, remains committed to its core business model of providing medical transcription service organizations (MTSOs) and healthcare providers a fully managed software suite to collect, store and move data with no up-front software costs or maintenance fees.

Olver, a commercial banking veteran who joined Emdat in February 2009 as a vice president, said upcoming years present a significant opportunity for the medical transcription industry. He said growth in electronic medical record (EMR) adoption and federal mandates make it more important than ever for medical notes and dictations to be integrated quickly and accurately.

“It’s a critical time for medical software and I am very confident in the ability of Emdat’s people and technology to evolve with industry changes and to set the pace for improvements,” Olver said. “There’s a heightened awareness within the medical community regarding ways that transcription software complements, rather than competes with, electronic medical records.”

Olver, a resident of Whitefish Bay, Wisconsin, earned a bachelor’s degree in business from the University of Wisconsin – Madison and a MBA from DePaul University. He worked at US Bank for 17 years and was most recently a senior vice president managing Milwaukee’s National Corporate Banking group.

ABOUT EMDAT
Emdat, Inc. (www.emdat.com), based in Fitchburg, Wisconsin, provides medical facilities and transcription service providers with flexible, seamless and cost-efficient solutions for fully managing medical transcription. Emdat provides one of the world’s leading transcription solutions serving more than 2,000 medical facilities throughout the United States and a network of hundreds of medical transcription companies around the globe.

###

Post Comment:
Trackback URL: http://www.prweb.com/pingpr.php/Q291cC1JbnNlLVBpZ2ctSGFsZi1FbXB0LVBpZ2ctWmVybw==

Technorati Tags

Bookmark -  Del.icio.us | Furl It | Technorati | Ask | MyWeb | Propeller | Live Bookmarks | Newsvine | TailRank | Reddit | Slashdot | Digg | Stumbleupon | Google Bookmarks | Sphere | Blink It | Spurl


OPTIONS
Printer Friendly Printer Friendly Version
Adobe PDF Download PDF Version
Adobe PDF Download Reader Version
Blog This BlogThis
Share This ShareThis
CONTACT INFORMATION
Colin Hutt
Emdat, Inc.
414-765-2311
Email us Here
ATTACHED FILES

Emdat Logo

Emdat Logo

ABOUT PRESS RELEASES
If you have any questions regarding information in these press releases please contact the company listed in the press release. Please do not contact PRWeb. We will be unable to assist you with your inquiry. PRWeb disclaims any content contained in these release. Our complete disclaimer appears here.
 
Close Move